PK and PD Within-Subject Variability of a Single Dose of Afrezza Inhaled Technosphere Insulin in Patients With Diabetes Mellitus Type 1 (T1DM)
Clinical trial NCT02485327 · COMPLETED
Trial details
- NCT number
- NCT02485327
- Sponsor
- Mannkind Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2015-11-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.